Acute intermittent porphyria, porphyria variegata and hereditary coproporphyria are called "inducible" porphyrias because clinical and biochemical manifestations of the disease may be induced by certain drugs or clinical situations.! Much has been written on the problems involved in anaesthetising patients with inducible porphyrias.!·5 To our knowledge, no case has been reported of a patient with porphyria undergoing cardiopulmonary bypass. This is relevant as anaesthesia for cardiac surgery with cardiopulmonary bypass involves the use of many drugs, hypothermia and contact with plastics, and it is often prolonged.
CASE HISTORY A 33-year-old male presented in June 1970 with abdominal pain of unknown origin. Investigation at that time led to a diagnosis of porphyria variegata. He presented in October 1970 with a rash on his face and hands, and again in November 1970 with abdominal pain and red urine. One brother had died of complications of porphyria. The patient had previously undergone tIve operations, including lumbar laminectomy and spinal fusions. The following agents had been used; thiopentone (twice), phenobarbitone, propanidid, diazepam, pethidine, papaveretum, pentazocine, promethazine, hyoscine, halothane (on four occasions), succinylcholine (twice) and tubocurarine (on three occasions). After a spinal fusion, abdominal pain occurred on the 12th post operative day. Urinary retention requiring catheterisation had occurred post operatively on two occasions.
Ten weeks before this admission, he had had his first episode of chest pain.
He was said to be pulseless when found by ambulance officers and resuscitated. After coronary angiography, subsequently performed under local anaesthesia with supplementary intravenous diazepam and atropine, he was transferred to St. Vincent's Hospital for surgery. At that time he was taking sorbide nitrite 5 mg sublingually every two hours and 20 mg orally every four hours, propranolol 80 mg orally four times a day, and glyceryl trinitrate ointment applied to the chest three times a day.
Examination at this time revealed slurred speech, very poor memory and skin changes suggestive of porphyria. Serum uric acid 1982 alkaline phosphatase and blood sugar were mildly elevated. Full blood count, clotting studies and serum electrolytes were normal. The chest X-ray and ECG were normal. His urinary porphobilinogen was zero, urinary amino laevulinic acid was 111 f../mol/day (normal < 40 f../mol/day). Total urinary porphyrins were 585 nmol/day (normal < 300 nmol/day).
Prior to his operation, the patient had several episodes of severe chest pain reqmnng intravenous morphine for relief. On the day of surgery he was premedicated with pethidine 75 mg, promethazine 25 mg and hyoscine 200 micrograms. A dextrose infusion was commenced. After preoxygenation, anaesthesia was induced with fentanyl 1.5 mg and diazepam 10 mg followed by pancuronium 10 mg. He was intubated and then ventilated with nitrous oxide and oxygen, 2: 1. Anaesthesia was supplemented with intermittent fentanyl. The only other agents given intraoperatively were cephalothin 2 g, heparin 18,000 units and protamine 300 mg.
The operation lasted three hours. The patient was on cardiopulmonary bypass for 70 minutes and was cooled to 30°C. He was extubated 4 hours after the completion of surgery. His blood sugar level was measured before, during, and after sUrgery. His urinary and faecal porphyrins, porphyrin precursors and urinary amino laevulinic acid levels were measured before and after surgery ( Table 1) .
Immediately after operation his total urinary porphyrin concentration was less than before operation and no porphobilinogen was detected in his urine. The presence of porphobilinogen in urine is considered early evidence of an episode of porphyria variegata. I Three hours after operation the urinary porphyrin concentration was 4.0 f../mol/l and porphobilinogen was detected in urine. The patient showed no symptoms or signs of acute porphyria. However, an infusion of haematin (4 mg/kg over 4 hours) was given. His bloodsugar level was maintained at approximately 10 mmol/l with a dextrose infusion.
Twenty-four hours after operation the urinary porphyrins were down to 1.8 f../mol/l. His urine was still positive for porphobilinogen so a second haematin infusion was given. The dextrose infusion was continued. On the second postoperative day (50 hours after surgery) a third infusion of haematin was given after which his urine remained negative for porphobilinogen. Full diet was commenced on day six after surgery and his dextrose infusion was ceased on day seven. He was discharged to his local hospital on day ten, having had no symptoms of porphyria variegata during the admission.
DISCUSSION
The term "porphyria" refers to a group of disorders of haem production. In each of these, there is a deficiency in the activity of a different enzyme. In normal subjects the rate-limiting step in the haem production pathway is that involving cl-amino laevulinic acid synthetase. This step undergoes feedback inhibition by haem. The enzyme defects in the porphyrias, by decreasing haem synthesis, cause a build-up of intermediate products of the steps between cl-amino laevulinic acid synthetase and the blocked enzyme.
In porphyria variegata, the defect may be in the enzyme ferrochetalase which catalyses the production of haem from protoporphyrin. It has also been suggested that the defect may be one step earlier in the production of protoporphyrin from protoporphyrinogen. 6 A large number of agents have been reported to trigger porphyria. Drugs which have been suggested to be trigger agents include althesin, barbiturates, benzodiazepines, ergot preparations, halothane, phenytoin, ketamine, tricyclic antidepressants and methyldopa. On this topic, the literature is often confusing, !4,71O probably because the trigger agents do not necessarily produce the clinical syndrome in susceptible patients on every exposure.! Therefore, small series showing the supposed safety of a certain drug in susceptible patients must be looked at with some scepticism as must a history of safe use of a drug in a susceptible patient. Apart from drugs, other triggers for porphyria have also been described. These include endogenous steroids, stress, infection and starvation. 2 In our patient, we attempted to avoid all trigger factors possible. It is known that starvation is able to induce increased activity of d-aminolaevulinic acid synthetase. A high blood-sugar level apparently blocks this induction. Therefore our patient received a dextrose infusion from the commencement of preoperative fasting until he was back on his full diet after surgery. It was set at a rate to keep his plasma glucose concentration at around 10 mmol/I. Despite his dextrose infusion and our efforts to avoid trigger agents during his anaesthetic, the patient showed biochemical evidence of an attack of porphyria within six hours of completion of the operation. This was determined by the finding of porphobilinogen in his urine.
There are several agents which may have been responsible for this. Though he was heavily premedicated, stress and endogenous steroid secretion stimulated by the anxiety that precedes a major operation may have been responsible. Chemicals leached out of the plastic tubing of the cardiopulmonary bypass circuit may have acted as trigger agents. With regard to this possibility, up to 16070 of nonporphyric patients undergoing haemodialysis for renal failure develop a porphyria-like syndrome.!2
Intravenous infusions of haematin have been shown to be dramatically effective in decreasing the activity of d-aminolaevulinic synthetase and switching off clinical episodes of porphyria.!!,!),!4 This therapy is not without serious complications. Haematin is produced by a series of crystallisation processes from old blood.!! An episode of reversible acute renal failure has been described in a patient who was rapidly infused with haematin.!!
